(Q34094061)

English

A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I study

scientific article

Statements

A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I study (English)
1 February 2010

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit